Phase 1 clinical trials are the first step in testing a new medicine in humans, focused on safety, tolerability and how the body processes the drug. In this video, we cover key study types such as SAD, MAD, food-effect, drug–drug interaction, bioavailability and bioequivalence, and how adaptive escalation methods like BOIN improve efficiency. We’ll show how integrated protocols streamline multiple parts into one design, reduce timelines and improve data consistency, plus share practical tips for planning a Phase 1 trial and avoiding common pitfalls.
At Quanticate, our experienced teams of statisticians, clinical pharmacologists and trial operations specialists work together to design and deliver Phase 1 trials that are safe, efficient and ready for regulatory success. From protocol concept to clean, reliable datasets, we help you get the most out of every participant and every data point. Submit an RFI today.
Bring your drugs to market with fast and reliable access to experts from one of the world’s largest global biometric Clinical Research Organizations.
© 2025 Quanticate